Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Letter to Shareholders
Newsletters
Q & A
Financial documents
General Shareholders’ meetings
Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
P
r
o
j
e
c
t
s
A
r
c
h
i
v
e
s
June 2022
Jennifer Wargo, MD, M.M.Sc
June 2022
Charles N. Serhan, PhD, DSc
June 2022
Miriam Merad, MD, PhD
June 2022
Bernard Malissen, PhD
June 2022
Sophie Brouard, PhD
June 2022
Wolf-Hervé Fridman, MD
October 2021
Nicolas Poirier, PhD
October 2021
Didier Hoch, MD
October 2021
Brigitte Dreno, MD
October 2021
Maryvonne Hiance
Précédent
1
2
3
Suivant